Intuitive Surgical: FY25 Q4 earnings call, Jan 22, 2026
No Kalshi or Polymarket word markets were listed for Intuitive Surgical’s Jan 22, 2026 earnings call (FY25 Q4). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
18 matches for “Ion”; 5 quoted, at least 25 words apart.
…multiport procedures growing 17% and single-port procedures growing 87%, combined with 51% Ion procedure growth, total procedures grew 19% for the year. In the U.S.,…
…3% across our da Vinci platforms. Multiport grew 3%; single-port, 29% and Ion, 9%. Turning to capital. We placed 1,721 da Vinci systems in 2025,…
…and we'll update you on our progress throughout the year. Turning to Ion. Worldwide procedures grew 51% to just over 144,000. Since FDA clearance in…
…results in the international markets. We are committed to expanding capabilities of Ion, including our efforts in ROSE, our rapid on-site tissue evaluation technology and…
…website. To facilitate a deepening of understanding of the trends within our Ion business, we have added disclosures to the data tables posted on our…
Agents: this page as TSV at /api/v1/appearances/intuitive-surgical:2026-01-22:earnings_call · words: /api/v1/brief?appearance=intuitive-surgical:2026-01-22:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP